ArticleMolecular and cellular biochemistry2025

The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling.

Darya Zibrova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.